OUTTHUNDER BETA

ARM

no-action Researched 2026-10-26 17:08 UTC

PriceDayYTD
Oct 23 close 210.33
Now 13:08 ET 221.10
+5.1%+102.3%

Trend

439.46289.80140.13↑ 226.07210.33↓ 196.13Volume34.2MClose21-day50-day200-dayApr 27Jul 28Oct 23

ARM is 20.2% (3.75 ATRs) below its 21-day average of $263.60, which is falling (-5.6% over 3 sessions), and 19.8% (3.67 ATRs) below its 50-day average of $262.40, also falling (-2.8% over 10 sessions). This is a downtrend, not simply a pullback.

Bull case
  • Reported fiscal Q1 2027 revenue was a record $1.29 billion, up 22.4% year over year. Growth in data-center CPUs and custom chip designs could extend demand beyond smartphones.
  • Management reportedly expects royalty growth in the “high teens.” If chip adoption and licensing continue to expand, Arm’s recurring royalty stream could turn broader chip demand into durable revenue growth.
Bear case
  • ARM fell 31.3% over one month versus SOXX’s 15.5% decline, underperforming by 15.8 percentage points. Its 0.85 correlation with SOXX makes continued semiconductor weakness a material risk.
  • The Qualcomm royalty question remains unresolved: the supplied evidence does not establish whether Qualcomm can stop paying royalties or materially impair Arm’s royalty growth. The thesis research explicitly says the evidence is inadequate to settle it.
  • Zacks cited a 34.99x forward price-to-sales ratio versus 4.48x for the industry on October 15. That reported premium leaves the shares vulnerable if expected growth disappoints or higher rates pressure long-duration valuations.
Reconciliation

Bullish growth coverage conflicts with ARM’s sharp decline and weakness versus semiconductors; I give the price and driver evidence more weight for entry timing, particularly because fundamental data are unavailable and the Qualcomm issue is unsettled.

Decision

Asked: I don't own it. I'm considering buying it for the long term.

  • Action: no-action.
  • Condition: Buy a starter position only after ARM records a daily close above $226.07, the reported 200-day average.
  • Timing: Wait for that trend-recovery signal, accepting the risk of paying more than the latest close—or missing the entry—rather than owning the current downtrend.
  • Distance: $226.07 is $15.74, or 7.5% and 1.11 ATRs, above the latest close; a move of that size is routine for ARM.
  • If-not-met: If the condition has not occurred by October 28, remain uninvested and reassess after the November 4 earnings report; do not chase without a new review.
  • Invalidation: A daily close below $196.13 before the review date would invalidate the near-term recovery setup and require a fresh assessment.
  • Forecast: 0.46 probability ARM beats SPY through the first close after its November 4 earnings report; its pronounced underperformance versus SOXX and falling averages pull the estimate below 0.50, partly offset by reported revenue growth.

Technical analysis: computed from daily prices as of 2026-10-23. Not an input to the decision above: each is scored against SPY on its own.

  • MACD (12, 26, 9): BEARISH, below its signal line, crossed 12 sessions ago (2026-10-07). Line -17.07, signal -9.91, histogram -7.16 and narrowing.
  • Awesome Oscillator (5, 34): BEARISH, below zero, crossed 8 sessions ago (2026-10-13). -49.20 and falling.
  • Chaikin Money Flow (20): BEARISH, selling pressure: volume is backing the down days, crossed 15 sessions ago (2026-10-02). -0.32 and rising.

Review triggers

  • Review-by: October 28, 2026 — FOMC rate decision.
  • Price-below: $196.13 (1.00 ATR below the latest close).
  • Price-above: $226.07 (1.11 ATR above the latest close).
  • Volume-above: 10,941K shares (the supplied 90th-percentile level).

The price triggers are within 2√3 ATRs of the latest close, so they are plausible before the review date.

Dive deep

Market overview of 2026-10-26 17:02 UTC →